Current status: 1095 hESC lines, 7294 hiPSC lines, and 182 clinical studies, and 2396 certificates
Monthly statistic from Aug 1, 2025
Posted on August 1, 2025
| total lines | 8389 |
| hESC lines | 1095 |
| hiPSC lines | 7294 |
| derivation countries | 50 |
| projects | 325 |
| providers | 999 |
| clinical studies | 182 |
| subclones | 3648 |
| certificates | 2396 |
| cell line certificates | 2244 |
| project certificates | 152 |